Combined Hepatitis B Virus and Hepatocellular Carcinoma Screening Using Point-of-Care Testing and Ultrasound in a Tanzanian Emergency Department

James S. Ford Department of Emergency Medicine, University of California, San Francisco, California;

Search for other papers by James S. Ford in
Current site
Google Scholar
PubMed
Close
,
Johnstone Kayandabila Department of Medicine, Arusha Lutheran Medical Center, Arusha, Tanzania;

Search for other papers by Johnstone Kayandabila in
Current site
Google Scholar
PubMed
Close
,
Joseph C. Morrison University of California Davis School of Medicine, Davis, California;

Search for other papers by Joseph C. Morrison in
Current site
Google Scholar
PubMed
Close
,
Samwel Seth Department of Medicine, Arusha Lutheran Medical Center, Arusha, Tanzania;

Search for other papers by Samwel Seth in
Current site
Google Scholar
PubMed
Close
,
Benson Lyimo Department of Surgery, Arusha Lutheran Medical Center, Arusha, Tanzania;

Search for other papers by Benson Lyimo in
Current site
Google Scholar
PubMed
Close
,
Aliasghar Mukhtar Department of Emergency Medicine, Arusha Lutheran Medical Center, Arusha, Tanzania;

Search for other papers by Aliasghar Mukhtar in
Current site
Google Scholar
PubMed
Close
,
Michael Schick Department of Emergency Medicine, University of California Davis Health, Sacramento, California;

Search for other papers by Michael Schick in
Current site
Google Scholar
PubMed
Close
,
Larissa May Department of Emergency Medicine, University of California Davis Health, Sacramento, California;

Search for other papers by Larissa May in
Current site
Google Scholar
PubMed
Close
, and
Jose D. Debes Department of Medicine, University of Minnesota, Minneapolis, Minnesota

Search for other papers by Jose D. Debes in
Current site
Google Scholar
PubMed
Close
Restricted access

ABSTRACT.

The WHO aims to detect 90% of global cases of hepatitis B virus (HBV) by 2030. Sub-Saharan Africa carries a disproportionate burden of HBV and hepatocellular carcinoma (HCC). In this study, we sought to assess the utility of a combined HBV and HCC screening program in Tanzania. We conducted a prospective, serial cross-sectional study of patients who participated in a combined HBV and HCC screening program at a regional referral hospital emergency department (ED) in Arusha, Tanzania, between April 19, 2022 and June 3, 2022. All patients completed a study questionnaire and were tested for HBV surface antigen. Patients who were HBV positive were screened for HCC via point-of-care ultrasound (POCUS). The primary outcome was the number of new HBV diagnoses. Data were analyzed with descriptive statistics. A total of 846 patients were tested for HBV (primary ED: 761, clinic referral: 85). The median age of patients was 44 ± 15 years, and 66% were female. Only 15% of patients reported having a primary care doctor. Thirteen percent of patients had been previously vaccinated for HBV. There were 17 new HBV diagnoses (primary ED: 16, clinic referral: 1), which corresponds to a seroprevalence of 2.0% (95% CI: 1.2%, 3.2%). No patients had liver masses detected on POCUS. An ED-based, combined HBV and HCC screening protocol can be feasibly implemented. This study could serve as a model for HBV/HCC screening in regions with high HBV endemicity and low rates of community screening.

Author Notes

Authors’ addresses: James S. Ford, Department of Emergency Medicine, University of California, San Francisco, CA, E-mail: james.ford@ucsf.edu. Johnstone Kayandabila and Samwel Seth, Department of Medicine, Arusha Lutheran Medical Center, Arusha, Tanzania, E-mails: johnskay3@hotmail.com and samwelseth@gmail.com. Joseph C. Morrison, University of California Davis School of Medicine, Davis, CA, E-mail: jcmorrison@ucdavis.edu. Benson Lyimo, Department of Surgery, Arusha Lutheran Medical Center, Arusha, Tanzania, E-mail: ben2harris@yahoo.com. Aliasghar Mukhtar, Department of Emergency Medicine, Arusha Lutheran Medical Center, Arusha, Tanzania, E-mail: aliasghar.mukhtar52@gmail.com. Michael Schick and Larissa May, Department of Emergency Medicine, University of California Davis Health, Sacramento, CA, E-mails: mschick@ucdavis.edu and lsmay@ucdavis.edu. Jose D. Debes, Department of Medicine, University of Minnesota, Minneapolis, MN, E-mail: debes003@umn.edu.

Address correspondence to James S. Ford, Department of Emergency Medicine, University of California, San Francisco, 490 Illinois St., Floor 7, San Francisco, CA 94158. E-mail: james.ford@ucsf.edu
  • 1.

    El-Serag HB , 2012. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142: 12641273.e1.

  • 2.

    Anna Kramvis MK , 2007. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 37 (Suppl 1 ):S9S19.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    McMahon BJ , 2018. Meeting the WHO and US goals to eliminate hepatitis B infection by 2030: opportunities and challenges. Clin Liver Dis (Hoboken) 12: 2932.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    The United Republic of Tanzania, Ministry of Health, Community Development, Elderly and Children , 2023. National Strategic Plan for the Control of Viral Hepatitis: 2018/19–2022/23. Available at: https://www.globalhep.org/sites/default/files/content/resource/files/2020-02/Tanzania%20National%20Strategic%20Plan%20for%20the%20Control%20of%20Viral%20Hepatitis%202018-19-2022-23.pdf. Accessed April 26, 2023.

    • PubMed
    • Export Citation
  • 5.

    Jaka H , Mshana SE , Rambau PF , Masalu N , Chalya PL , Kalluvya SE , 2014. Hepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting. World J Surg Oncol 12: 246.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Yang JD et al., 2017. Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium. Lancet Gastroenterol Hepatol 2: 103111.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Yang JD , Hainaut P , Gores GJ , Amadou A , Plymoth A , Roberts LR , 2019. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16: 589604.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Yang JD et al., 2015. Hepatocellular carcinoma occurs at an earlier age in Africans, particularly in association with chronic hepatitis B. Am J Gastroenterol 110: 16291631.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    McNaughton AL et al., 2020. Hepatitis B virus seroepidemiology data for Africa: modelling intervention strategies based on a systematic review and meta-analysis. PLoS Med 17: e1003068.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Ford JS , Marianelli LG , Frassone N , Debes JD , 2020. Hepatitis B screening in an Argentine ED: increasing vaccination in a resource-limited setting. Am J Emerg Med 38: 296299.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Tanaka H , 2020. Current role of ultrasound in the diagnosis of hepatocellular carcinoma. J Med Ultrason (2001) 47: 239255.

  • 12.

    Revill PA et al., 2019. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol 4: 545558.

  • 13.

    Bonafide CP , Brady PW , Keren R , Conway PH , Marsolo K , Daymont C , 2013. Development of heart and respiratory rate percentile curves for hospitalized children. Pediatrics 131: e1150e1157.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Harris PA , Taylor R , Thielke R , Payne J , Gonzalez N , Conde JG , 2009. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42: 377381.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Kilonzo SB , Gunda DW , Mpondo BCT , Bakshi FA , Jaka H , Hepatitis B , 2018. Virus infection in Tanzania: current status and challenges. J Trop Med 2018: 4239646.

  • 16.

    Schweitzer A , Horn J , Mikolajczyk RT , Krause G , Ott JJ , 2015. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386: 15461555.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Miller WC , Shao JF , Weaver DJ , Shimokura GH , Paul DA , Lallinger GJ , 1998. Seroprevalence of viral hepatitis in Tanzanian adults. Trop Med Int Health 3: 757763.

  • 18.

    Pellizzer G , Blè C , Zamperetti N , Stroffolini T , Upunda G , Rapicetta M , Chionne P , Villano U , Fabris P , de Lalla F , 1994. Serological survey of hepatitis B infection in Tanzania. Public Health 108: 427431.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Muro FJ , Fiorillo SP , Sakasaka P , Odhiambo C , Reddy EA , Cunningham CK , Buchanan AM , 2013. Seroprevalence of hepatitis B and C viruses among children in Kilimanjaro Region, Tanzania. J Pediatric Infect Dis Soc 2: 320326.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Aaron D , Nagu TJ , Rwegasha J , Komba E , 2017. Hepatitis B vaccination coverage among healthcare workers at national hospital in Tanzania: how much, who and why? BMC Infect Dis 17: 786.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Mavilia MG , Wu GY , 2017. Mechanisms and prevention of vertical transmission in chronic viral hepatitis. J Clin Transl Hepatol 5: 119129.

  • 22.

    Kew MC , 2013. Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. Ann Hepatol 12: 173182.

Past two years Past Year Past 30 Days
Abstract Views 2056 2056 71
Full Text Views 77 77 1
PDF Downloads 95 95 1
 
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save